1. Accueil >
  2. Vistin Pharma ASA : Minutes from Extraordinary General Meeting >
Nasdaq

Vistin Pharma ASA : Minutes from Extraordinary General Meeting

02-11-2017

Vistin Pharma ASA (OSE: VISTIN), please find attached the minutes from the extraordinary general meeting held on 2 November 2017. All matters were resolved as proposed in the call for the extraordinary general meeting.

For further information, please contact:

Gunnar Manum


CFO


+47 95 17 91 90


gunnar.manum@vistin.com

 
 
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.


This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Vistin Pharma ASA via GlobeNewswire

HUG#2146807